Zvra Stock Analysis Zevra Therapeutics Inc. Biotech Rises 2.36 Percent To 9.54 20260401 1 GTIM Q1 2026 Earnings Positive EPS Amidst Limited Disclosures MasTec MTZ Q1 2026 Earnings EPS Surges 39 Above Estimates Stock Slips Despite Strong Beat ASPS Q1 2026 Earnings EPS Exceeds Estimates by 349 Shares Surge KFY Q1 2026 Earnings EPS Beats Estimates Stock Rises on Solid Performance Pixelworks Q1 2026 Earnings Stunning EPS Beat Overshadowed by Revenue Ambiguity